GB Patent

GB2542192A — Chewable medicament

Assigned to Revolymer UK Ltd · Expires 2017-03-15 · 9y expired

What this patent protects

Chewing gum compositions comprising at least one biologically active ingredient, a chewing gum base and at least one sweetening or flavouring agent are described, in which the gum compositions have a compression modulus of less than 7 kPa. The gum compositions exhibit improved pa…

USPTO Abstract

Chewing gum compositions comprising at least one biologically active ingredient, a chewing gum base and at least one sweetening or flavouring agent are described, in which the gum compositions have a compression modulus of less than 7 kPa. The gum compositions exhibit improved patient compliance when compared with prior art gums, as well as offering improved release characteristics of the active ingredient contained therein.

Drugs covered by this patent

Patent Metadata

Patent number
GB2542192A
Jurisdiction
GB
Classification
—
Expires
2017-03-15
Drug substance claim
No
Drug product claim
No
Assignee
Revolymer UK Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.